✦ LIBER ✦

New Dual Inhibitors of EGFR and HER2 Protein Tyrosine Kinases.

✍ Scribed by Brian E. Fink; et al. et al.

Publisher: John Wiley and Sons
Year: 2006
Weight: 25 KB
Volume: 37
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200605166

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New C-5 Substituted Pyrrolotriazine Dual

New C-5 Substituted Pyrrolotriazine Dual Inhibitors of EGFR and HER2 Protein Tyrosine Kinases.

✍ Harold Mastalerz; et al. et al. 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 15 KB

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Discovery and Biological Evaluation of P

Discovery and Biological Evaluation of Potent Dual ErbB-2/EGFR Tyrosine Kinase Inhibitors: 6-Thiazolylquinazolines.

✍ Karen Lackey; et al. et al. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 16 KB 👁 2 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

Targeting EGFR and HER-2 Receptor Tyrosi

Targeting EGFR and HER-2 Receptor Tyrosine Kinases for Cancer Drug Discovery and Development

✍ Shantaram Kamath; John K. Buolamwini 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 8 KB

Targeting EGFR and HER-2 receptor tyrosi

Targeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development

✍ Shantaram Kamath; John K. Buolamwini 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB

Conventional anticancer therapy using cytotoxic drugs lacks selectivity and is prone to toxicity and drug resistance. Anticancer therapies targeting aberrant growth factor receptor signaling are gaining interest. The erbB receptor family belongs to the type I, the receptor tyrosine kinases class, an

The dual EGFR/HER-2 tyrosine kinase inhi

The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38

✍ Melissa J. LaBonte; Philipp C. Manegold; Peter M. Wilson; Will Fazzone; Stan G. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 482 KB

## Abstract Members of the human epidermal receptor (HER) family are frequently associated with aggressive disease and poor prognosis in multiple malignancies. Lapatinib is a dual tyrosine kinase inhibitor targeting the epidermal growth factor receptor (EGFR) and HER‐2. This study evaluated the the

ChemInform Abstract: Synthesis and Evalu

ChemInform Abstract: Synthesis and Evaluation of Novel Pyrimidine-Based Dual EGFR/Her-2 Inhibitors.

✍ Naoyuki Suzuki; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 22 KB